Reuter Uwe Rudolf Max, Oettmeier Ralf, Hobohm Uwe
Uwe Rudolf Max Reuter (UR), Klinik-im-LEBEN, Gartenweg 5, 07973, Greiz, Germany.
Ralf Oettmeier (RO), Paracelsusklinik, Battenhusstrasse 12, 9053 Teufen, Switzerland.
Transl Oncol. 2018 Apr;11(2):330-337. doi: 10.1016/j.tranon.2018.01.019. Epub 2018 Feb 7.
William Coley, between 1895 and 1936, treated hundreds of cancer patients using infusions of fever inducing bacerial extracts. Similar experiments were done by Klyuyeva and co-workers in the 1940ies in Russia using trypanosoma extracts. Many remissions and cures were reported. We have conjectured that pathogen associated molecular pattern substances (PAMP) are the molecular explanation for the beneficial treatments in both groups. We could show that a combination of PAMP can eradicate solid tumours in cancer mice if applied several times. Accordingly, we suggested to combine PAMP containing approved drugs to treat cancer patients using a protocol similar to the old fever induction regimen. In this retrospective phase-1 study we report on the fever induction capacity and safety of applications of bacterial extracts, combinations of bacterial extracts with approved drugs, and combinations of approved drugs in 131 mainly cancer patients. Adverse reactions were those which can be expected during a feverish infection and mild. Over 523 fever inductions, no severe adverse reaction was observed.
1895年至1936年间,威廉·科利使用能引起发热的细菌提取物输液治疗了数百名癌症患者。20世纪40年代,俄罗斯的克柳耶娃及其同事使用锥虫提取物进行了类似实验。报告了许多病情缓解和治愈的案例。我们推测,病原体相关分子模式物质(PAMP)是两组有益治疗的分子解释。我们能够证明,如果多次应用,PAMP组合可以根除癌症小鼠体内的实体瘤。因此,我们建议将含有PAMP的已批准药物联合使用,采用类似于旧的发热诱导方案的方案来治疗癌症患者。在这项回顾性1期研究中,我们报告了131名主要为癌症患者使用细菌提取物、细菌提取物与已批准药物的组合以及已批准药物组合的发热诱导能力和安全性。不良反应是发热感染期间可能出现的且较为轻微。在超过523次发热诱导过程中,未观察到严重不良反应。